WallStreetZenWallStreetZen

NASDAQ: ARTV
Artiva Biotherapeutics Inc Earnings Dates, Reports, Calls

OverviewForecastEarnings
RevenueDividendOwnership
Artiva Biotherapeutics earnings were -$90.8M for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. The latest ARTV earnings report on Jun 30, 2026 announced Q2 2026 earnings of -$25.0M, up 6.3% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, ARTV reported annual earnings of -$83.9M, with 28.3% growth. The next ARTV earnings date is Nov 11, 2026.

ARTV earnings history

Current Revenue
$0.0
Current Earnings
-$90.8M
Current Profit Margin
0%

ARTV Return on Equity

Current Company
-53.9%
Current Industry
-13.6%
Current Market
30.9%
ARTV's Return on Equity (-53.9%)... subscribe to Premium to read more.
High Return on Equity Performance

ARTV Return on Assets

Current Company
-48.2%
Current Industry
-10.3%
ARTV is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

Be the first to know when ARTV announces earnings.

ARTV Return on Capital Employed

Current Company
-25.65%
Current Industry
-7%

ARTV vs Biotech Stocks

TickerEBITDAEarningsY/Y EarningsEPS
ARTV-$88.14M-$90.82MN/A-$3.30
CCCC-$93.70M-$101.42MN/A-$0.91
EDIT-$73.54M-$73.95MN/A-$0.69
ZURA-$84.93M-$116.45MN/A-$1.13
AVIR-$171.37M-$165.29MN/A-$2.08
View Top Biotech Stocks

ARTV earnings dates

Next earnings date
Nov 11, 2026

Artiva Biotherapeutics Earnings Reports & History FAQ

What were Artiva Biotherapeutics's earnings last quarter?

On ARTV's earnings call on Aug 5, 2026, Artiva Biotherapeutics (NASDAQ: ARTV) reported Q2 2026 earnings per share (EPS) of -$0.63, up 27.59% year over year. Total ARTV earnings for the quarter were -$25.01 million. In the same quarter last year, Artiva Biotherapeutics's earnings per share (EPS) was -$0.87.

If you're new to stock investing, here's how to buy Artiva Biotherapeutics stock.

When does Artiva Biotherapeutics report earnings?

The next ARTV earnings call is Nov 11, 2026. Add ARTV to your watchlist to be reminded of Artiva Biotherapeutics's next earnings date.

Is Artiva Biotherapeutics profitable or losing money?

As of the last Artiva Biotherapeutics earnings report, Artiva Biotherapeutics is currently losing money. Artiva Biotherapeutics's net profit (also called net income) for the twelve months ending Jun 30, 2026 was -$90.82 million, a 20.88% increase year over year.

What was ARTV's earnings growth in the past year?

As of Artiva Biotherapeutics's earnings date in Aug 5, 2026, Artiva Biotherapeutics's earnings has grown year over year. ARTV earnings in the past year totalled -$90.82 million.

What are Artiva Biotherapeutics's earnings expectations?

The current EPS estimate for Artiva Biotherapeutics's earnings report in Nov 11, 2026 is -$0.54.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.